ArticleCureus2025

Response Assessment of Generic Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Prospective Study from a Tertiary Care Centre in North Eastern India.

Ananya Choudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.